Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Tourmaline Bio Inc (NASDAQ: TRML) was $16.30 for the day, down -8.68% from the previous closing price of $17.85. In other words, the price has decreased by -$8.68 from its previous closing price. On the day, 0.67 million shares were traded. TRML stock price reached its highest trading level at $18.05 during the session, while it also had its lowest trading level at $15.56.
Ratios:
Our analysis of TRML’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 40.33 and its Current Ratio is at 40.33. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on April 23, 2025, initiated with a Buy rating and assigned the stock a target price of $70.
On March 06, 2025, Wedbush started tracking the stock assigning a Outperform rating and target price of $42.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $50.BMO Capital Markets initiated its Outperform rating on December 06, 2024, with a $50 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 21 ’24 when Kulkarni Sandeep Chidambar bought 1,779 shares for $14.85 per share. The transaction valued at 26,418 led to the insider holds 7,000 shares of the business.
Kulkarni Sandeep Chidambar bought 5,221 shares of TRML for $71,998 on Aug 16 ’24. The CEO now owns 5,221 shares after completing the transaction at $13.79 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TRML now has a Market Capitalization of 418722528 and an Enterprise Value of 169612208.
Stock Price History:
The Beta on a monthly basis for TRML is 2.12, which has changed by 0.04958141 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, TRML has reached a high of $29.79, while it has fallen to a 52-week low of $11.56. The 50-Day Moving Average of the stock is 7.60%, while the 200-Day Moving Average is calculated to be -15.02%.
Shares Statistics:
TRML traded an average of 357.54K shares per day over the past three months and 382320 shares per day over the past ten days. A total of 25.68M shares are outstanding, with a floating share count of 16.04M. Insiders hold about 37.56% of the company’s shares, while institutions hold 68.30% stake in the company. Shares short for TRML as of 1744675200 were 3062762 with a Short Ratio of 8.57, compared to 1741910400 on 3410038. Therefore, it implies a Short% of Shares Outstanding of 3062762 and a Short% of Float of 13.340001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
